Good manufacturing practices (GMP) principles play a vital role in the pharmaceutical and biotechnology industry. Adherence to GMP standards for manufacturing facilities, equipment, and processes helps assure the safety and efficacy of drug products.
This month, our speakers will share a wealth of knowledge and expertise in pharmaceutical development, discussing issues to consider for early-stage drug developers and steps to take (or pitfalls to avoid) to enhance the chances of success with GMP.
Join us at 2 p.m. March 13 to learn more about the practical requirements of GMP as part of developing any drug, including small molecules, biologics, and gene therapy.
Guest Speakers
Stephen Hoag, PhD
Professor, Department of Pharmaceutical Sciences
Director, Applied Pharmaceutics Lab
University of Maryland School of Pharmacy
Suman Subramanian
Head of Commercial Operations Gene Therapy
Catalent Pharma Solutions
Register at bit.ly/UMBInno-March